OFELIA
BANIANDRÉS RODRÍGUEZ
Profesora asociada de Ciencias de la Salud
M.
LLamas Velasco
Publicacions en què col·labora amb M. LLamas Velasco (17)
2024
-
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
International Journal of Dermatology, Vol. 63, Núm. 4, pp. 503-511
-
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice
Experimental Dermatology, Vol. 33, Núm. 8
-
Ustekinumab is effective and safe in the long-term treatment of erythrodermic psoriasis: Multicenter study in daily practice
JEADV Clinical Practice, Vol. 3, Núm. 2, pp. 604-610
2023
-
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice
Journal of the European Academy of Dermatology and Venereology
-
High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting
International Journal of Dermatology
2022
-
Effectiveness and safety profile of secukinumab for the treatment of patients with generalized pustular psoriasis in daily practice
Journal of the European Academy of Dermatology and Venereology
-
Knowledge and role of dermatologists in life-threatening infections: a national survey among hospital skin specialists
Journal of the European Academy of Dermatology and Venereology
-
Risankizumab in psoriasis: prior biologics failure does not impact on short-term effectiveness
Expert Opinion on Biological Therapy
2021
-
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
Journal of the American Academy of Dermatology, Vol. 84, Núm. 2, pp. 513-517
-
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain
Dermatology and Therapy, Vol. 11, Núm. 6, pp. 2207-2215
2020
-
A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg
Dermatologic Therapy, Vol. 33, Núm. 4
-
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases
British Journal of Dermatology, Vol. 183, Núm. 1, pp. 71-77
-
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry
Journal of the American Academy of Dermatology, Vol. 83, Núm. 1, pp. 139-150
-
Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study
Dermatologic Therapy, Vol. 33, Núm. 6
-
The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study
Journal of the American Academy of Dermatology, Vol. 82, Núm. 3, pp. 738-741
2019
2018
-
Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study
Journal of the American Academy of Dermatology, Vol. 78, Núm. 4, pp. 798-800